← Insider buys
STML

Stemline Therapeutics Inc

COO Kenneth Hoberman sold $290K of Stemline Therapeutics Inc

Sold$289,702
$11.11Price
26,082Shares
−3%Stake

What STML did after the filing

Prices for STML after this filing aren't in yet.

Traded Mon, Mar 11. Filed Fri, Mar 15, 5:00 PM ET, after the close. Not investment advice.